Public Health Aspects of Breast Cancer Gene Testing in Canada Part 2: Selection for and Effects of Testing

Chronic Diseases in Canada

Volumn 20, Issue 1, 1999, Pages 14-20

  Elwood, J Mark ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Attitude to health; Breast neoplasms; Decision making; Genetic counselling; Genetic screening; Ovarian tumours; Risk

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; BREAST TUMOR; DECISION SUPPORT SYSTEM; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; GENETICS; HUMAN; MIDDLE AGED; OVARY TUMOR; PATIENT SELECTION; PSYCHOLOGICAL ASPECT; RISK;

ADULT; AGED; ATTITUDE TO HEALTH; BREAST NEOPLASMS; DECISION SUPPORT TECHNIQUES; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PATIENT SELECTION; RISK;

EID: 0032601712     PISSN: 02288699     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Elwood JM. Public health aspects of breast cancer gene testing in Canada. Part 1: Risks and interventions. Chronic Dis Can 1999;20(1):3-13.
2. Elwood JM. Public health aspects of breast cancer gene testing in Canada. Part 3: A model of potential need and demand. Chronic Dis Can 1999;20(1):21-5.
3. Brown ML, Kessler LG. The use of gene tests to detect hereditary predisposition to cancer: economic considerations. J Natl Cancer Inst 1995;87:1131-6.
4. Davis JG. Predictive genetic tests: problems and pitfalls. Ann N Y Acad Sci 1997;833:42-6.
5. Brody LC, Biesecker BB. Breast cancer susceptibility genes BRCA1 and BRCA2. Medicine 1998;77:208-26.
6. Collins FS. BRCA1 - lots of mutations, lots of dilemmas. N Engl J Med 1996;334:186-8.
7. Weber BL, Giusti RM, Liu ET. Developing strategies for intervention and prevention in hereditary breast cancer. J Natl Cancer Inst 1995;17:99-102.
8. Evans DGR, Fentiman IS, McPherson K, Asbury D, Ponder BAJ, Howell A. Familial breast cancer. BMJ 1994;308:183-7.
9. Greene MH. Genetics of breast cancer. Mayo Clin Proc 1997;72:54-65.
10. American Society of Human Genetics. Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Genet 1994;55:471-4.
11. Shattuck Eidens D, McClure M, Simard J, et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 1995;273:535-41.
12. Cannon-Albright LA, Skolnick MH. The genetics of familial breast cancer. Semin Oncol 1996;23:1-5.
13. Couch FJ, DeShano ML, Blackwood MA, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997;336:1409-15.
14. Shattuck-Evans D, Oliphant A, McClure M, et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing. JAMA 1997;278:1242-50.
15. Eeles R. Testing for the breast cancer predisposition gene, BRCA1. Documenting the outcome in gene carriers is essential. BMJ 1996;313:572-3.
16. Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 1997;89:227-38.
17. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995;57:1457-62.
18. Parmigiani G, Berry DA, Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998;62:145-58.
19. Schmidt S, Becher H, Chang-Claude J. Breast cancer risk assessment: use of complete pedigree information and the effect of misspecified ages at diagnosis of affected relatives. Hum Genet 1998;102:348-56.
20. Lerman C, Croyle RT. Genetic testing for cancer predisposition: behavioral science issues. Monogr Natl Cancer Inst 1995;17:63-6.
21. de Silva D, Gilbert F, Needham G, Deans H, Turnpenny P, Haites N. Identification of women at high genetic risk of breast cancer through the National Health Service Breast Screening Programme (NHSBSP). J Med Genet 1995;32:862-6.
22. Benkendorf JL, Reutenauer JE, Hughes CA, et al. Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility. Am J Med Genet 1997;73:296-303.
23. Lerman C, Biesecker B, Benkendorf JL, et al. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 1997;89:148-57.
24. Tambor ES, Rimer BK, Strigo TS. Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. Am J Med Genet 1997;68:43-9.
25. Wooster R, Neuhausen S, Mangion J. Localisation of a breast cancer susceptibility gene, BRCA2, to chromosome 13q 12-13. Science 1994;265:2088-90.
26. Croyle RT, Lerman C. Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Prev Med 1993;22:284-92.
27. Smith KR, Croyle RT. Attitudes toward genetic testing for colon cancer risk. Am J Public Health 1995;85:1435-8.
28. Craufurd D, Dodge A, Kerzin-Storrar L, Harris R. Uptake of presymptomatic predictive testing for Huntington's disease. Lancet 1989;2:603-5.
29. Thirlaway K, Fallowfield L. The psychological consequences of being at risk of developing breast cancer. Eur J Cancer Prev 1993;2:467-71.
30. Durfy SJ, Buchanan TE, Burke W. Testing for inherited susceptibility to breast cancer: a survey of informed consent forms for BRCA1 and BRCA2 mutation testing. Am J Med Genet 1998;75:82-7.
31. Macdonald KG, Doan B, Kelner M, Taylor KM. A sociobehavioural perspective on genetic counselling and testing for susceptibility to breast, ovarian and colon cancer. Can Med Assoc J 1996;154:457-64.
32. Bottorff JL, Ratner PA, Johnson JL, Lovato CY, Joab SA. Uncertainties and challenges: communicating risk in the context of familial cancer. Report to the National Cancer Institute of Canada. Vancouver: School of Nursing and Institute of Health Promotion Research, University of British Columbia; 1996:1-97.
33. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86.
34. Black WC, Nease RF, Jr., Tosteson ANA. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 1995;87:720-31.
35. Lerman C, Kash K, Stefanek M. Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. Monogr Natl Cancer Inst 1994;171-6.
36. Audrain J, Lerman C, Rimer B, Cella D, Steffens R, Gomez-Caminero A. Awareness of heightened breast cancer risk among first-degree relatives of recently diagnosed breast cancer patients. Cancer Epidemiol Biomarkers Prev 1995;4:561-5.
37. Lerman C, Rimer BK, Daly M, et al. Recruiting high risk women into a breast cancer health promotion trial. Cancer Epidemiol Biomarkers Prev 1994;3:271-6.
38. Richardson JL, Mondrus GT, Deapen D, Mack TM. Future challenges in secondary prevention of breast cancer for women at high risk. Cancer 1994;74:1474-81.
39. Lerman C, Schwartz M. Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res Treat 1993;28:145-55.
40. Kash KM, Holland JC, Halper MS, Miller DG. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992;84:24-30.
41. Kash KM, Holland JC, Osborne MP, Miller DG. Psychological counseling strategies for women at risk of breast cancer. Monogr Natl Cancer Inst 1995;17:73-9.
42. Lerman C, Lustbader E, Rimer B, et al. Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 1995;87:286-92.
43. Evans DGR, Blair V, Greenhalgh R, Hopwood P, Howell A. The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer 1994;70:934-8.
44. Geller G, Bernhardt BA, Doksum T, Helzsouer KJ, Wilcox P, Holtzman NA. Decision-making about breast cancer susceptibility testing: how similar are the attitudes of physicians, nurse practitioners, and at-risk women? J Clin Oncol 1998;16:2868-76.
45. Audrain J, Rimer B, Cella D, et al. Genetic counselling and testing for breast-ovarian cancer susceptibility testing: what do women want? J Clin Oncol 1998;16:133-8.
46. Esplen MJ, Toner B, Hunter J, Glendon G, Butler K, Field B. A group therapy approach to facilitate integration of risk information for women at risk for breast cancer. Can J Psychiatry 1998;43:375-80.
47. Green MJ, Fost N. An interactive computer program for educating and counseling patients about genetic susceptibility to breast cancer. J Cancer Educ 1997;12:204-8.
48. Winter PR, Wiesner GL, Finnegan J, et al. Notification of a family history of breast cancer: issues of privacy and confidentiality. Am J Med Genet 1996;66:1-6.
49. Lerman C, Narod S, Schulman K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA 1996;275:1885-92.
50. Lerman C, Hughes C, Lemon SJ, et al. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol 1998;16:1650-4.
51. Botkin JR, Croyle RT, Smith KR, et al. A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 Testing. J Natl Cancer Inst 1996;88:872-82.
52. Croyle RT, Smith KR, Botkin JR, Baty B, Nash J. Psychological responses to BRCA1 mutation testing preliminary findings. Health Psychol 1997;16:63-72.
53. Lynch HT, Lemon SJ, Durham C, et al. A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer 1997;79:2219-28.